Category: Investment Expert

Foresite Capital’s CEO, Jim Tananbaum, And Other Investors Finance Mindstrong Health

Mindstrong Health has just completed its series-A funding that saw them raise $14 million. This fund shall be channeled towards enhancing the company’s neuropsychiatric treatment and diagnosis platform. This innovative platform seeks to study brain function through interactions on smartphone devices. It will monitor the patient’s processing speed, memory, attention and executive functions of the brain. The financing round was made a success courtesy of the contributions made by Jim Tananbaum’s Foresite Capital, ARCH Ventures, Optum Ventures, One Mind Brain Health Impact fund and Berggruen Holdings. The results of the clinical trial of tracking mental health will be released later. Jim Tananbaum said that Mindstrong Health has zeroed in on the critical challenges facing the medical community. He said that the new platform will improve patient‘s outcome and help physicians to modernize their healthcare systems. Check out Crunchbase to know more.

About Jim Tananbaum

Jim Tananbaum serves as the founding CEO of Foresite Capital, a renowned healthcare growth equity firm. Dr. Jim has an extensive experience in the field of healthcare entrepreneurship and investment considering that he has been in the industry for over two decades. Foresite Capital specializes in financial and strategic operational opportunities to build disruptive healthcare brands. The company’s largest investment is Intarcia, a renowned entity that develops type II diabetes implants that help patients to control the disease and lose weight. Notably, Foresite Capital has also financed a revered healthcare franchise known as Aeri Pharmaceuticals. The company develops glaucoma treatment. The other companies that have benefited from Jim Tananbaum’s services are Sequenta, 10X, Nanostring, Editas, Intellia amd Muse Bio.

Jim Tananbaum is the co-founder of Geltex Pharmaceuticals. The company is known for manufacturing two drugs at a lesser cost. It was later sold for $1.6 million. In addition, Jim co-founded Prospect Venture Partners II and III, and Theravance. The shrewd investor holds an M.D. and MBA from Harvard University and a BS and BSEE from Yale. He is also an alumnus of the Massachusetts Institute of Technology (MIT) where he earned his master’s degree. Recently, Jim was named on Forbes’ Midas List of Top Tech Investors. The program seeks to honor top 100 venture capitalists that make exceptional investments in the leading tech companies of the next generation. The Midas list also recognizes the leaders who create impressive value for their investors.

See more: http://www.massdevice.com/neuropsych-treatment-diagnosis-platform-dev-mindstrong-health-raises-14m-series/

Services Offered By UKV PLC

UKV PLC Wines company has a network of negotiators, merchants and traders all over Europe. It specializes in wine trade. The aim is to help people sell their wine stock. It has a collective investment portfolio where an investor receives a share of the wine collection. The collection is managed by the company with various options available for selling if the client so wishes.

The wines company has a free no obligation valuation. The aim of valuation is to make sure the wine sells fast. Before the wine is listed on company stock, a minimum price is agreed after which it sells the wine through a brokerage service. UKV PLC Wines takes a 10 percent commission of the selling price.

The option of independent valuation through wine merchants and brokers is available. The objective is to get an unbiased value of the wine from a third party. The best of the offers is considered before selling the wine.

The interest of UKV PLC Wines is to buy quality wine. Some people have wine stocks on bond, if interested in selling the company offers free valuation. On the other hand, simply go for a straight sale. In a straight sale, the company buys wine directly after valuation and makes an offer. Offers are based on the price that a similar wine will attract on the market.

Selling wine through brokerage service requires stock transfer to the bonded trade account. The purpose is to perform verification of its condition. Verification involves checking the actual wine case, bottle labels, and the level of the wine. If the conditions are satisfactory, the wine is sold on an open market.

Clients of UKV PLC Wines enjoy a 2.5 percent commission. The commission is charged on the selling price and not on where the wine came from.

Read more on Behance.net

All The Facts On CCMP Capital and Stephen Murray

All There is to Know About CCMP Capital

Voted 17th in the world’s largest equity funds, Stephen Murray CCMP Capital is a private investment firm that has a main goal of putting all of their attention of the leveraged buyout and the growth status of the transactions that are done with the Capital. Becoming an independent firm in August of 2006, CCMP Capital has over 50 people working side-by-side with them currently. One thing most people do not know about CCMP is that they have many different offices, they even have offices in Tokyo, New York, Hong Kong and London. They are the experts in the buyout and growth process of equity investments, even in Europe and North America. They are in four different types of industries too. The CCMP of CCMP Capital is actually a derivative of the company’s ancestor companies, Chase Capital, Chemical Venture, Manufacturers Hanover, Capital/J.P. Morgan and Partners.

The History That Goes With CCMP Capital

Over the span of the last 20 years, the CCMP Capital company has been known by many different names. CCMP Capital was founded in 1984, and when it was originally founded, the founders had decided to name it Chemical Venture Partners. Since the very beginning of the company, Stephen Murray CCMP Capital was supposed to be a private equity and venture capital are for the Chemical Bank company. The acquisition of the Chase Manhattan Bank, in 1996, happened around the same time that Chemical Bank had made the decision to take the Chase name for their company and then the Chemical Venture Partners had decided that they would become the Chase Capital Partners to everyone. After this all happened, the name kept changing, but the values still stayed the same, making them a great company to work with.

The President and Chief Executive Officer Stephen P. Murray

As an investor in private equity and his career as a philanthropist, Stephen Murray was known as a great business man. He earned his title as the President and Chief Executive Officer of the company CCMP Capital very quickly. The year 1984 was a great year for Stephen, it was when he had put his mind to joining the Manufacturers Hanover’s Corporation credit analyst training program. Soon after joining the credit analyst training program, he became a part of the MH Equity Corporation, in 1989. Being a mix of the Manufacturers Hanover’s private equity group and leveraged finance department, the MH Equity Corporation was an amazing company to work with. JP Morgan Partners soon had Murray in charge of the buyout business of their company. In 2004, Murray became the co-founder of the CCMP Capital company in August. They, just one year later, in 2007, the CCMP Capital company dubbed him as the CEO of CCMP Capital.